Literature DB >> 21557270

Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry.

Michael N Okobia1, Joseph M Zmuda, Robert E Ferrell, Alan L Patrick, Clareann H Bunker.   

Abstract

BACKGROUND: Earlier studies on the role of germline variations in the disproportionate higher burden of prostate cancer in men of African ancestry have been largely unrewarding. However, the successful replication of recent genome-wide association findings implicating some regions of chromosome 8q24 in the disparate prostate cancer susceptibility in men of European and African ancestry have been encouraging. This case-control study was designed to evaluate the association between germline variations in chromosome 8q24 and prostate cancer risk in Afro-Caribbean Tobago men, a population of predominantly West African ancestry.
METHODS: High molecular weight genomic DNA was isolated from blood clots using Qiagen kits. Genotyping was performed on genomic DNA using a pre-designed TaqMan SNP assay according to the manufacture's protocol on a 7900HT Fast Real-Time PCR system (Applied Biosystems, Foster City, CA).
RESULTS: SNP rs16901979 in region 2 was associated with significantly increased risk of prostate cancer (OR = 1.41, 95% confidence interval [CI] 1.02-1.95, P = 0.04) with the risk stronger in men with early-onset prostate cancer (OR = 2.37, 95% CI 1.40-3.99, P = 0.001). There was a tendency towards significantly increased risk for SNPs rs1447295 and rs6983267 in men with early-onset prostate cancer.
CONCLUSIONS: The replication of the association of chromosome 8q24 variants with increased prostate cancer risk in Tobago men and the higher frequency of the risk alleles in controls in populations of African ancestry further strengthens the possible role of this genomic region in the disproportionate higher burden of prostate cancer in men of African ancestry.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21557270      PMCID: PMC4422491          DOI: 10.1002/pros.21320

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  30 in total

1.  Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence.

Authors:  A Valeri; L Briollais; R Azzouzi; G Fournier; P Mangin; P Berthon; O Cussenot; F Demenais
Journal:  Ann Hum Genet       Date:  2003-03       Impact factor: 1.670

2.  A common variant associated with prostate cancer in European and African populations.

Authors:  Laufey T Amundadottir; Patrick Sulem; Julius Gudmundsson; Agnar Helgason; Adam Baker; Bjarni A Agnarsson; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Jean-Baptiste Cazier; Jesus Sainz; Margret Jakobsdottir; Jelena Kostic; Droplaug N Magnusdottir; Shyamali Ghosh; Kari Agnarsson; Birgitta Birgisdottir; Louise Le Roux; Adalheidur Olafsdottir; Thorarinn Blondal; Margret Andresdottir; Olafia Svandis Gretarsdottir; Jon T Bergthorsson; Daniel Gudbjartsson; Arnaldur Gylfason; Gudmar Thorleifsson; Andrei Manolescu; Kristleifur Kristjansson; Gudmundur Geirsson; Helgi Isaksson; Julie Douglas; Jan-Erik Johansson; Katarina Bälter; Fredrik Wiklund; James E Montie; Xiaoying Yu; Brian K Suarez; Carole Ober; Kathleen A Cooney; Henrik Gronberg; William J Catalona; Gudmundur V Einarsson; Rosa B Barkardottir; Jeffrey R Gulcher; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2006-05-07       Impact factor: 38.330

3.  Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.

Authors:  Matthew L Freedman; Christopher A Haiman; Nick Patterson; Gavin J McDonald; Arti Tandon; Alicja Waliszewska; Kathryn Penney; Robert G Steen; Kristin Ardlie; Esther M John; Ingrid Oakley-Girvan; Alice S Whittemore; Kathleen A Cooney; Sue A Ingles; David Altshuler; Brian E Henderson; David Reich
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

4.  Multiple prostate cancer risk variants on 8q24.

Authors:  John S Witte
Journal:  Nat Genet       Date:  2007-05       Impact factor: 38.330

5.  The epidemiology of prostate cancer in Jamaica.

Authors:  F E Glover; D S Coffey; L L Douglas; M Cadogan; H Russell; T Tulloch; T D Baker; R L Wan; P C Walsh
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

6.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

Authors:  Julius Gudmundsson; Patrick Sulem; Andrei Manolescu; Laufey T Amundadottir; Daniel Gudbjartsson; Agnar Helgason; Thorunn Rafnar; Jon T Bergthorsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Jianfeng Xu; Thorarinn Blondal; Jelena Kostic; Jielin Sun; Shyamali Ghosh; Simon N Stacey; Magali Mouy; Jona Saemundsdottir; Valgerdur M Backman; Kristleifur Kristjansson; Alejandro Tres; Alan W Partin; Marjo T Albers-Akkers; Javier Godino-Ivan Marcos; Patrick C Walsh; Dorine W Swinkels; Sebastian Navarrete; Sarah D Isaacs; Katja K Aben; Theresa Graif; John Cashy; Manuel Ruiz-Echarri; Kathleen E Wiley; Brian K Suarez; J Alfred Witjes; Mike Frigge; Carole Ober; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; Lambertus A Kiemeney; William B Isaacs; William J Catalona; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

7.  The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.

Authors:  J K Gohagan; P C Prorok; R B Hayes; B S Kramer
Journal:  Control Clin Trials       Date:  2000-12

8.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.

Authors:  Eugenia E Calle; Carmen Rodriguez; Eric J Jacobs; M Lyn Almon; Ann Chao; Marjorie L McCullough; Heather S Feigelson; Michael J Thun
Journal:  Cancer       Date:  2002-05-01       Impact factor: 6.860

9.  Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus.

Authors:  Christiane Robbins; Jada Benn Torres; Stanley Hooker; Carolina Bonilla; Wenndy Hernandez; Angela Candreva; Chiledum Ahaghotu; Rick Kittles; John Carpten
Journal:  Genome Res       Date:  2007-10-31       Impact factor: 9.043

10.  Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.

Authors:  T Visakorpi; A H Kallioniemi; A C Syvänen; E R Hyytinen; R Karhu; T Tammela; J J Isola; O P Kallioniemi
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

View more
  21 in total

1.  Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.

Authors:  Chiara Grisanzio; Lillian Werner; David Takeda; Bisola C Awoyemi; Mark M Pomerantz; Hiroki Yamada; Prasanna Sooriakumaran; Brian D Robinson; Robert Leung; Anna C Schinzel; Ian Mills; Helen Ross-Adams; David E Neal; Masahito Kido; Toshihiro Yamamoto; Gillian Petrozziello; Edward C Stack; Rosina Lis; Philip W Kantoff; Massimo Loda; Oliver Sartor; Shin Egawa; Ashutosh K Tewari; William C Hahn; Matthew L Freedman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-22       Impact factor: 11.205

2.  Common variants at 8q24 are associated with prostate cancer risk in Serbian population.

Authors:  Ana S Branković; Goran N Brajušković; Jovan D Mirčetić; Zorana Z Nikolić; Predrag B Kalaba; Vinka D Vukotić; Saša M Tomović; Snežana J Cerović; Zoran A Radojičić; Dušanka L J Savić-Pavićević; Stanka P Romac
Journal:  Pathol Oncol Res       Date:  2013-03-28       Impact factor: 3.201

3.  8q24 risk alleles and prostate cancer in African-Barbadian men.

Authors:  Cheryl D Cropp; Christiane M Robbins; Xin Sheng; Anselm J M Hennis; John D Carpten; Lyndon Waterman; Ronald Worrell; Tae-Hwi Schwantes-An; Jeffrey M Trent; Christopher A Haiman; M Cristina Leske; Suh-Yuh Wu; Joan E Bailey-Wilson; Barbara Nemesure
Journal:  Prostate       Date:  2014-09-22       Impact factor: 4.104

4.  8q24 risk alleles in West African and Caribbean men.

Authors:  Adam B Murphy; Flora Ukoli; Vincent Freeman; Frankly Bennett; William Aiken; Trevor Tulloch; Kathleen Coard; Fru Angwafo; Rick A Kittles
Journal:  Prostate       Date:  2012-01-10       Impact factor: 4.104

5.  Interactions of PVT1 and CASC11 on Prostate Cancer Risk in African Americans.

Authors:  Hui-Yi Lin; Catherine Y Callan; Zhide Fang; Heng-Yuan Tung; Jong Y Park
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-03-26       Impact factor: 4.254

6.  Pathological Roles of Reactive Oxygen Species in Male Reproduction.

Authors:  Saptaparna Chakraborty; Shubhadeep Roychoudhury
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  Fine-mapping of IL16 gene and prostate cancer risk in African Americans.

Authors:  Ken Batai; Ebony Shah; Adam B Murphy; Jennifer Newsome; Maria Ruden; Chiledum Ahaghotu; Rick A Kittles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-24       Impact factor: 4.254

8.  Variants on 8q24 and prostate cancer risk in Chinese population: a meta-analysis.

Authors:  Xiao-Qiang Ren; Jian-Guo Zhang; Shi-Yong Xin; Tao Cheng; Liang Li; Wei-Hua Ren
Journal:  Int J Clin Exp Med       Date:  2015-06-15

9.  The Establishment of the First Cancer Tissue Biobank at a Hispanic-Serving Institution: A National Cancer Institute-Funded Initiative between Moffitt Cancer Center in Florida and the Ponce School of Medicine and Health Sciences in Puerto Rico.

Authors:  Idhaliz Flores; Teresita Muñoz-Antonia; Jaime Matta; Miosotis García; David Fenstermacher; Sylvia Gutierrez; Edward Seijo; Jose' Torres-Ruiz; W Jack Pledger; Domenico Coppola
Journal:  Biopreserv Biobank       Date:  2011-11-10       Impact factor: 2.300

10.  Cohesin is required for activation of MYC by estradiol.

Authors:  Miranda V McEwan; Michael R Eccles; Julia A Horsfield
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.